⚠️ This content is not available in English.

Authors

[:fr]Anselmi G[:],
[:fr]Vaivode K[:],
[:fr]Ramos RN[:],
[:fr]Missolo-Koussou Y[:],
[:fr]Hidalgo S[:],
[:fr]Tosselo J[:],
[:fr]Nuñez N[:],
[:fr]Richer W[:],
[:fr]Vincent-Salomon A[:],
[:fr]Saxena A[:],
[:fr]Wood K[:],
[:fr]Lladser A[:],
[:fr]Piaggio E[:],
[:fr]Helft J[:],

[:fr]

Abstract

Dendritic cells (DCs) are antigen-presenting cells controlling T cell activation. In humans, the diversity, ontogeny, and functional capabilities of DC subsets are not fully understood. Here, we identified circulating CD88CD1c+CD163+ DCs (called DC3s) as immediate precursors of inflammatory CD88CD14+CD1c+CD163+FcεRI+ DCs. DC3s develop via a specific pathway activated by GM-CSF, independent of cDC-restricted (CDP) and monocyte-restricted (cMoP) progenitors. Like classical DCs but unlike monocytes, DC3s drove activation of naive T cells. In vitro, DC3s displayed a distinctive ability to prime CD8+ T cells expressing a tissue homing signature and the epithelial homing alpha-E integrin (CD103) through transforming growth factor β (TGF-β) signaling. In vivo, DC3s infiltrated luminal breast cancer primary tumors, and DC3 infiltration correlated positively with CD8+CD103+CD69+ tissue-resident memory T cells. Together, these findings define DC3s as a lineage of inflammatory DCs endowed with a strong potential to regulate tumor immunity.

[:en]

Abstract

Dendritic cells (DCs) are antigen-presenting cells controlling T cell activation. In humans, the diversity, ontogeny, and functional capabilities of DC subsets are not fully understood. Here, we identified circulating CD88CD1cCD163 DCs (called DC3s) as immediate precursors of inflammatory CD88CD14CD1cCD163FcεRI DCs. DC3s develop via a specific pathway activated by GM-CSF, independent of cDC-restricted (CDP) and monocyte-restricted (cMoP) progenitors. Like classical DCs but unlike monocytes, DC3s drove activation of naive T cells. In vitro, DC3s displayed a distinctive ability to prime CD8 T cells expressing a tissue homing signature and the epithelial homing alpha-E integrin (CD103) through transforming growth factor β (TGF-β) signaling. In vivo, DC3s infiltrated luminal breast cancer primary tumors, and DC3 infiltration correlated positively with CD8CD103CD69 tissue-resident memory T cells. Together, these findings define DC3s as a lineage of inflammatory DCs endowed with a strong potential to regulate tumor immunity.

[:]

Other publications

Authors :
Bex-Coudrat Julie,
Victoria Peter,
Chaimae Saji,
Claire Dupont,
Mathilde Lavernhe,
Suoqin Jin,
Chapart Lea,
Gautier Gregory,
Thibaudeau Olivier,
Thaminy Morgane,
Tchen John,
Simon Quentin,
Xing Dai,
Kensuke Miyake,
Hajime Karasuyama,
Jean X Jiang,
Karmella Naidoo,
Benhamou Marc,
Blank Ulrich,
Monteiro Renato,
Graham Le Gros,
Agnès Coste,
Nicolas Charles,
Pellefigues Christophe,
Find out more
Authors :
Maïté Lewin,
Rauda Aldhaheri,
Beaufrère Aurélie,
Christophe Desterke,
Anita Paisant,
Ivan Bricault,
Paul Borde,
Gabriel Simon,
Lesurtel Mickaël,
Daniel Cherqui,
Clara Prud'Homme,
Vilgrain Valérie,
Astrid Laurent-Bellue,
Find out more
Authors :
Penney Jake,
Victor Nardon,
Beaufrère Aurélie,
Albuquerque Miguel,
Paradis Valérie,
Sinkus Ralph,
Find out more